McMaster University

McMaster University

Faculty of
Health Sciences

Biography of Mark Levine

Published: June 30, 2016
Mark Levine
Dr. Mark Levine, professor and chair, Department of Oncology; Buffett Taylor Chair in Breast Cancer Research

Dr. Mark Levine is a professor of oncology and holds the Buffett Taylor Chair in Breast Cancer Research.

Levine earned his medical degree at McGill University in his native Montreal. He completed his residency in internal medicine at McMaster University before training in hematology and oncology at Duke University Medical Centre in the U.S. He returned to McMaster in 1981.

He has been chair of the Department of Oncology for the Michael G. DeGroote School of Medicine at McMaster since 2007. He is also a medical oncologist at the Juravinski Cancer Centre of Hamilton Health Sciences, and he was CEO of the cancer centre between 1992 and 1999. He established the Escarpment Cancer Research Institute of McMaster University and Hamilton Health Sciences in 2011.

He is renowned as a clinician researcher conducting studies that have impacted health care in Canada and beyond.

In patients with early breast cancer, for example, he has shortened the length of chemotherapy after surgery; added a new chemotherapy drug, Epirubicin, after surgery to improve survival; and pioneered work on shared decision making to enhance communication between oncologist and patient on treatment choices.

He led a landmark trial that showed that patients with venous blood clots in the leg could be treated at home with low molecular weight heparin rather than be treated in hospital with blood thinners.

As well, for the past 30 years he has been the director of the Ontario Clinical Oncology Group (OCOG) which conducts cancer clinical trials. More than 12,000 patients have participated in these studies in a number of cancer types. Of particular note are studies that evaluated novel radiation regimens in early breast cancer and prostate cancer.

He has more than 300 peer-reviewed journal publications.

Valid XHTML 1.0 Transitional Level Double-A conformance, W3C WAI Web Content Accessibility Guidelines 2.0